InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
2
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Olivo Martin Sebastian, Directeur Médical. Director active across 1 company, notably Protara Therapeutics, Inc.. Cumulatively, 2 reports have been logged. Breakdown: 2 buys · 0 sell. Total volume traded: €82k. History available since 10 June 2021. The latest transaction was disclosed on 10 June 2021 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Declarations2 total
4,959 shares@ US$10.0850.0% of flowCommon StockSEC:0001209191-21-040311
Ideal exit: 7 Mar 2022 (T+270)
4,959 shares@ US$10.080.014% mcap50.0% of flowCommon StockSEC:0001209191-21-040311:0
Ideal exit: 7 Mar 2022 (T+270)
2 of 2 declarations
About Olivo Martin Sebastian
Martin Sebastian Olivo serves as the Chief Medical Officer at Protara Therapeutics, Inc. In this role, he oversees the company's medical and strategic initiatives. Olivo brings clinical and scientific expertise, contributing to the advancement of therapeutic treatments.
